Skip to main content

Table 1 Clinical characteristics, blood-test data, and co-existing diseases in patients with angiodysplasia and gastric antral vascular ectasia (GAVE)

From: Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhage

  Angiodysplasia
N = 27
GAVE
N = 19
P value
Age, years, mean ± SD* 71.6 ± 10.2 61.8 ± 11.9 0.005
Gender, M/F 15/12 11/8 0.875
Hemoglobin level (g/L), mean ± SD* 84.0 ± 32.0 82.0 ± 21.0 0.971
Platelet count (×109/L), mean ± SD* 162.3 ± 84.2 142.1 ± 111.4 0.192
Prothrombin time (sec), mean ± SD* 11.1 ± 1.5 11.1 ± 3.3 0.551
Activated partial thromboplastin time (sec), mean ± SD* 30.1 ± 5.1 27.0 ± 2.8 0.095
Active blood oozing on endoscopy, n (%) 19 (70.4) 17 (89.5) 0.160
Liver cirrhosis, n (%) 7 (25.9) 12 (63.2) 0.012
End-stage renal disease, n (%) 6 (22.2) 2 (10.5) 0.440
Hepatoma, n (%) 5 (18.5) 7 (36.8) 0.19
§Transarterial embolization, n (%) 2 (7.4) 6 (31.6) 0.051
§Radiation therapy, n (%) 1 (3.7) 5 (26.3) 0.068
  1. * SD: 1 standard deviation
  2. § as previous treatment for hepatoma